T.Rx Capital
Overview
T.Rx Capital is a venture capital firm that invests in early-stage companies at the intersection of technology and biology, focusing on biotechnology, digital health, and tech-enabled services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Synchron | Nov 2025 | Series D | Co-investor |
| ImmuneBridge | Mar 2026 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is T.Rx Capital based?
T.Rx Capital is headquartered in Boston, Massachusetts, United States.
When was T.Rx Capital founded?
T.Rx Capital was founded in 2023.
How many portfolio companies does T.Rx Capital have?
T.Rx Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in T.Rx Capital's portfolio?
Portfolio companies visible on Caplight include Synchron, ImmuneBridge.
What was T.Rx Capital's most recent investment shown here?
T.Rx Capital's most recent investment in this portfolio sample was in ImmuneBridge in 2026.
What sectors does T.Rx Capital focus on?
T.Rx Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does T.Rx Capital focus on?
T.Rx Capital typically invests at the Early stage.
What is T.Rx Capital's AUM?
T.Rx Capital's assets under management are estimated between $77.5M and $77.5M.